0169-4804 : Rybelsus 4 mg Oral Tablet


NDC: 0169-4804
Labeler: Novo Nordisk
Product Type: Human Prescription Drug
Drug Name:  Rybelsus
Dosage Form: Oral Tablet
Application #: NDA213051
Rev. Date: 


Active Ingredients:

  • Semaglutide

Dosage Strength:

  • 4 mg

Pharmaceutical Classes:

  • GLP-1 Receptor Agonist [EPC]
  • Glucagon-Like Peptide 1 [CS]
  • Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

Related Products:

Based on records with the same trade name.
  • 0169-4303 Rybelsus 3 mg Oral Tablet by Novo Nordisk
  • 0169-4307 Rybelsus 7 mg Oral Tablet by Novo Nordisk
  • 0169-4314 Rybelsus 14 mg Oral Tablet by Novo Nordisk
  • 0169-4809 Rybelsus 9 mg Oral Tablet by Novo Nordisk
  • 0169-4815 Rybelsus 1.5 mg Oral Tablet by Novo Nordisk

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0169-4804 QR Code

< Prev: 0169-4772Next: 0169-4809 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.